Hypertension in young adults with autosomal dominant polycystic kidney disease: a case for early screening?
- PMID: 37260997
- PMCID: PMC10229279
- DOI: 10.1093/ckj/sfad049
Hypertension in young adults with autosomal dominant polycystic kidney disease: a case for early screening?
Abstract
ADPKD is the most common hereditary kidney disease and a major cause of kidney failure world-wide. Significant kidney enlargement occurs decades preceding loss of kidney function. However, the earliest clinical manifestations of disease have been less well characterized in young adults, a typically healthy population who do not often seek routine medical care. In this study, Martinez and colleagues report a high prevalence of hypertension among young adults (18-30 years) enrolled in the Spanish ADPKD registry REPQRAD. Their findings confirm previous studies in children and young adults with ADPKD and make a strong case for earlier screening and intervention within this age group.
Keywords: ADPKD; age; ambulatory blood pressure monitoring; cardiovascular; hypertension.
© The Author(s) 2023. Published by Oxford University Press on behalf of the ERA.
Conflict of interest statement
M.A.C. reports having received consultancy fees and serving on the paediatric research steering committee for Otsuka Pharmaceuticals, Inc.
Figures

Comment in
- doi: 10.1093/ckj/sfac251
Similar articles
-
Autosomal dominant polycystic kidney disease in young adults.Clin Kidney J. 2022 Nov 29;16(6):985-995. doi: 10.1093/ckj/sfac251. eCollection 2023 Jun. Clin Kidney J. 2022. PMID: 37260991 Free PMC article.
-
The spectrum of autosomal dominant polycystic kidney disease in children and adolescents.Pediatr Nephrol. 2017 Jan;32(1):31-42. doi: 10.1007/s00467-016-3364-y. Epub 2016 Mar 31. Pediatr Nephrol. 2017. PMID: 27034070 Review.
-
The Clinical Manifestation and Management of Autosomal Dominant Polycystic Kidney Disease in China.Kidney Dis (Basel). 2016 Oct;2(3):111-119. doi: 10.1159/000449030. Epub 2016 Oct 6. Kidney Dis (Basel). 2016. PMID: 27921038 Free PMC article. Review.
-
Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease.Nephrol Dial Transplant. 2017 Feb 1;32(2):342-347. doi: 10.1093/ndt/gfw013. Nephrol Dial Transplant. 2017. PMID: 28186577 Free PMC article.
-
Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.Rev Port Cardiol. 2007 Nov;26(11):1173-82. Rev Port Cardiol. 2007. PMID: 18297839 English, Portuguese.
References
-
- Mekahli DG-W LG, Cadnapaphornchai MA, Greenbaum LGet al. . Randomized, placebo-controlled, phase 3B trial of tolvaptan in the treatment of children and adolescents with autosomal dominant polycystic kidney disease (ADPKD): 1-year data. Nephrol Dial Transplant 2021;36:i89–90.
Publication types
LinkOut - more resources
Full Text Sources